Please read these important legal notices and disclosures
None of the information displayed on or downloadable from https://www.precize.in represents an offer to buy or sell or a solicitation of an offer to buy or sell any security, nor does it constitute an offer to provide investment advice or service. Registered representatives of precize do not (1) Advise any member on the merits or advisability of a particular investment or transaction, or (2) Assist in the determination of fair value of any security or investment, or (3) Provide legal, tax, or transactional advisory services.
Veeda Clinical Research Unlisted Share Price Today
52-week range ₹442 to ₹499.
ISIN INE01HQ01026.
About Company Veeda Clinical Research is an India-based clinical research organization (CRO), providing integrated services across the drug development lifecycle to global pharmaceutical and biotechnology companies. The company primarily focuses on early-phase clinical research, including Phase I studies, bioequivalence and bioavailability studies, food-effect studies, and experimental medicine trials. Veeda operates through a science-led, asset-intensive model supported by in-house cli…
Veeda Clinical Research
About Company
Veeda Clinical Research is an India-based clinical research organization (CRO), providing integrated services across the drug development lifecycle to global pharmaceutical and biotechnology companies. The company primarily focuses on early-phase clinical research, including Phase I studies, bioequivalence and bioavailability studies, food-effect studies, and experimental medicine trials.
Veeda operates through a science-led, asset-intensive model supported by in-house clinical, bioanalytical, and regulatory capabilities, enabling it to serve complex and regulated clinical programs. Its long-term client engagements and repeat business underpin a scalable operating model with scope for operating leverage as capacity utilisation improves.
